Biotechnology Companies By Ebitda

EBITDA
EBITDAEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
18.1 B
 0.38 
 0.89 
 0.34 
2AMGN Amgen Inc
7.9 B
 0.02 
 1.39 
 0.03 
3GILD Gilead Sciences
7.61 B
(0.06)
 1.83 
(0.11)
4GMAB Genmab AS
5.65 B
(0.11)
 2.10 
(0.23)
5BNTX BioNTech SE
4.11 B
(0.08)
 2.18 
(0.17)
6REGN Regeneron Pharmaceuticals
4.05 B
 0.25 
 1.11 
 0.27 
7VRTX Vertex Pharmaceuticals
3.93 B
 0.16 
 2.03 
 0.32 
8BIIB Biogen Inc
2.6 B
(0.05)
 1.70 
(0.08)
9HLN Haleon Plc
2.16 B
 0.02 
 1.45 
 0.03 
10UTHR United Therapeutics
1.39 B
(0.05)
 1.63 
(0.09)
11GRFS Grifols SA ADR
978.58 M
(0.07)
 5.42 
(0.41)
12INCY Incyte
904.74 M
 0.06 
 2.03 
 0.12 
13ALKS Alkermes Plc
486.73 M
 0.08 
 2.89 
 0.24 
14HALO Halozyme Therapeutics
422.43 M
 0.01 
 2.41 
 0.02 
15NBIX Neurocrine Biosciences
416.1 M
 0.13 
 1.63 
 0.20 
16BMRN Biomarin Pharmaceutical
261.98 M
(0.08)
 1.53 
(0.12)
17INDV Indivior PLC Ordinary
249 M
 0.11 
 4.48 
 0.47 
18ZYME Zymeworks Common Stock
210.72 M
 0.16 
 3.00 
 0.48 
19IRWD Ironwood Pharmaceuticals
210.61 M
 0.00 
 5.47 
 0.00 
20EXEL Exelixis
196.6 M
(0.01)
 1.74 
(0.02)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.